EOS looks for MelaFind partners:
This article was originally published in Clinica
Electro-Optical Sciences is seeking commercialisation partners for its hand-held melanoma scanner, which it anticipates launching in mid-2008, subject to US regulatory clearance. Its device, called MelaFind, is a noninvasive, point-of-care instrument that emits light of multiple wavelengths to capture images of suspicious pigmented skin lesions and extract data. Using algorithms, the data are then analysed against a proprietary database of melanomas and benign lesions to provide information to the physician, and produce a recommendation of whether the lesion should be biopsied. Patient accrual in a final blinded pivotal trial of the device is over 20% complete, said the Irvington, New York firm. Four pivotal study sites are active, and additional pivotal trial sites will be activated in the upcoming weeks.